Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Medicina Clinica (English Ed.)|June 28, 2022
Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infectionRicardo Rubini-Costa, Francisco Bermúdez-Jiménez, Ricardo Rivera-López, et al.
Medicina Clinica (English Ed.)|July 5, 2022
Association of blood group A with hospital comorbidity in patients infected by SARS-CoV-2Álvaro Tamayo-Velasco, María Teresa Jiménez García, Alba Sanchez Rodríguez, et al.
Medicina Clinica (English Ed.)|May 31, 2021
Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammationIsmael Francisco Aomar-Millán, Juan Salvatierra, Úrsula Torres-Parejo, et al.
Medicina Clinica (English Ed.)|July 12, 2021
Encephalitis as a neurological manifestation of COVID-19Herminia Lozano Gómez, Ana Pascual Bielsa, Paula Abansés Moreno, et al.
Medicina Clinica (English Ed.)|July 11, 2022
Cardiopulmonary Exercise Testing in Patients with Post-COVID-19 SyndromeLeandro Barbagelata, Walter Masson, Diego Iglesias, et al.
Medicina Clinica (English Ed.)|August 25, 2020
Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infectionJosé Luis Callejas Rubio, Juan de Dios Luna Del Castillo, Javier de la Hera Fernández, et al.
Medicina Clinica (English Ed.)|June 20, 2023
Lung ultrasound score severity cut-off points in COVID-19 pneumonia. A systematic review and validating cohortJaime Gil-Rodríguez, Michel Martos-Ruiz, Alberto Benavente-Fernández, et al.
Medicina Clinica (English Ed.)|October 19, 2020
Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortalityMario Rivera-Izquierdo, María Del Carmen Valero-Ubierna, Juan Luis R-delAmo, et al.
Medicina Clinica (English Ed.)|October 6, 2020
Collateral benefits on other respiratory infections during fighting COVID-19Khee-Siang Chan, Fu-Wen Liang, Hung-Jen Tang, et al.
Medicina Clinica (English Ed.)|October 12, 2020
The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trialHaiming Cui, Feng Wu, Zhenyu Fan, et al.
Pageof 11